{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:18:43Z","timestamp":1787678323690,"version":"build-2784847793"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"HEAL Data2Action Modeling and Economic Resource Center","award":["U24 DA057650"],"award-info":[{"award-number":["U24 DA057650"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The potential of methadone maintenance treatment (MMT) to address the opioid crisis has been limited by restrictive federal and local policies that require frequent clinic visits for medication. Unprecedented federal regulatory changes started in early COVID-19 and were made permanent in 2024, allowing clinics increased flexibility in granting take-home medication to patients. Medicaid payment policies can profoundly shape provider behaviors but may not align with regulatory changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic synthesis of Medicaid MMT payment and billing policies among 40 states over March 2020-July 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>More than half of the states continued to adopt a per-dose or per-diem approach to paying for methadone dosing and a per-service approach to paying for addiction counseling, thus tying Medicaid revenue closely to clinic visits. More than one-quarter maintained a flat bundled payment dating back to prepandemic era that provided little incentive for granting patients more than 1 week of take-home medication. Adoption of a 2-tiered bundled payment modeled after Medicare's payment increased over time but remained limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Medicaid payment policies for MMT saw limited changes over the 5 years following initial federal regulatory changes. Practice changes toward more flexible and patient-centered care may be hindered without compatible changes in payment approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/haschl\/qxag195","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:55:06Z","timestamp":1785412506000},"source":"Crossref","is-referenced-by-count":0,"title":["Medicaid payment policies for methadone maintenance treatment for opioid use disorder, 2020-2025"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3825-4327","authenticated-orcid":false,"given":"Yuhua","family":"Bao","sequence":"first","affiliation":[{"name":"Department of Population Health Sciences, Weill Cornell Medicine , New York, NY 10022 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4689-1408","authenticated-orcid":false,"given":"Promi","family":"Chakraborty","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Weill Cornell Medicine , New York, NY 10022 ,","place":["United States"]},{"name":"Sophie Davis Biomedical Education Program, CUNY School of Medicine , New York, NY 10031 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Hutchings","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Weill Cornell Medicine , New York, NY 10022 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6363-2839","authenticated-orcid":false,"given":"Shashi N","family":"Kapadia","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Weill Cornell Medicine , New York, NY 10022 ,","place":["United States"]},{"name":"Department of Medicine, Weill Cornell Medicine , New York, NY 10065 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7396-3938","authenticated-orcid":false,"given":"Noa","family":"Krawczyk","sequence":"additional","affiliation":[{"name":"Department of Population Health, NYU School of Medicine , New York, NY 10016 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R","family":"Schackman","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Weill Cornell Medicine , New York, NY 10022 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6307-6369","authenticated-orcid":false,"given":"Barbara","family":"Andraka-Christou","sequence":"additional","affiliation":[{"name":"School of Global Health Management and Informatics, University of Central Florida , Orlando, FL 32816 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5201-3557","authenticated-orcid":false,"given":"Ju-Chen","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Celia Scott Weatherhead School of Public Health and Tropical Medicine, Tulane University , New Orleans, LA 70112 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"issue":"21","key":"2026082512221229200_qxag195-B1","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1001\/jama.2024.16954","article-title":"Buprenorphine\/naloxone vs methadone for the treatment of opioid use disorder","volume":"332","author":"Nosyk","year":"2024","journal-title":"JAMA"},{"key":"2026082512221229200_qxag195-B2","author":"Volkow"},{"key":"2026082512221229200_qxag195-B3","doi-asserted-by":"publisher","DOI":"10.17226\/26635","volume-title":"Methadone Treatment for Opioid Use Disorder: Improving Access through Regulatory and Legal Change: Proceedings of a Workshop","author":"National Academies of Sciences, Engineering, and Medicine; Action Collaborative on Countering the U.S. Opioid Epidemic; Health and Medicine Division; Board on Health Care Services; Board on Health Sciences Policy","year":"2022"},{"issue":"1","key":"2026082512221229200_qxag195-B4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12954-021-00535-y","article-title":"It's like \u201cliquid handcuffs\u201d: the effects of take-home dosing policies on methadone maintenance treatment (MMT) patients' lives","volume":"18","author":"Frank","year":"2021","journal-title":"Harm Reduct J"},{"key":"2026082512221229200_qxag195-B5","author":"Substance Abuse and Mental Health Services Administration"},{"key":"2026082512221229200_qxag195-B6","author":"Federal Register"},{"key":"2026082512221229200_qxag195-B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108449","article-title":"Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19","volume":"131","author":"Brothers","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"S2","key":"2026082512221229200_qxag195-B8","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.2105\/AJPH.2021.306665","article-title":"The methadone manifesto: treatment experiences and policy recommendations from methadone patient activists","volume":"112","author":"Simon","year":"2022","journal-title":"Am J Public Health"},{"issue":"6","key":"2026082512221229200_qxag195-B9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/ADM.0000000000000981","article-title":"Shifting medication treatment practices in the COVID-19 pandemic: a statewide survey of Pennsylvania opioid treatment programs","volume":"16","author":"Krawczyk","year":"2022","journal-title":"J Addict Med"},{"key":"2026082512221229200_qxag195-B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108801","article-title":"Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: a mixed methods analysis","volume":"141","author":"Hoffman","year":"2022","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"2026082512221229200_qxag195-B11","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/08897077.2022.2060438","article-title":"The idea is to help people achieve greater success and liberty\u201d: a qualitative study of expanded methadone take-home access in opioid use disorder treatment","volume":"43","author":"Suen","year":"2022","journal-title":"Subst Abus"},{"key":"2026082512221229200_qxag195-B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108219","article-title":"Reimagining patient-centered care in opioid treatment programs: lessons from the Bronx during COVID-19","volume":"122","author":"Joseph","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"2026082512221229200_qxag195-B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2024.111283","article-title":"Methadone dosing at New York State opioid treatment programs following initial revisions to federal regulations","volume":"258","author":"Jordan","year":"2024","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"2026082512221229200_qxag195-B14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s10488-015-0673-6","article-title":"A prospective examination of clinician and supervisor turnover within the context of implementation of evidence-based practices in a publicly-funded mental health system","volume":"43","author":"Beidas","year":"2016","journal-title":"Adm Policy Ment Health"},{"key":"2026082512221229200_qxag195-B15","author":"SAMHSA"},{"issue":"1","key":"2026082512221229200_qxag195-B16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13011-022-00478-y","article-title":"Medicaid professional fees for treatment of opioid use disorder varied widely across states and were substantially below fees paid by medicare in 2021","volume":"17","author":"Clemans-Cope","year":"2022","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"2026082512221229200_qxag195-B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2024.209547","article-title":"Payment and billing strategies to support methadone take-home medication: perspectives of financial leaders of opioid treatment program organizations in New York State","volume":"168","author":"Bao","year":"2024","journal-title":"J Subst Use Addict Treat."},{"key":"2026082512221229200_qxag195-B18","author":"Centers for Medicare & Medicaid Services"},{"key":"2026082512221229200_qxag195-B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.209214","article-title":"State guidance and system changes related to COVID-19: impact on opioid treatment programs","volume":"158","author":"Fuller","year":"2023","journal-title":"J Subst Use Addict Treat."},{"key":"2026082512221229200_qxag195-B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2024.209357","article-title":"Substance use disorder treatment carve outs in Medicaid managed care","volume":"161","author":"Silverman","year":"2024","journal-title":"J Subst Use Addict Treat."},{"key":"2026082512221229200_qxag195-B21","author":"Wayback Machine"},{"key":"2026082512221229200_qxag195-B22","author":"Montana Department of Public Health and Human Services"},{"key":"2026082512221229200_qxag195-B23","author":"Montana Department of Public Health and Human Services"},{"key":"2026082512221229200_qxag195-B24","author":"Centers for Medicare & Medicaid Services"},{"issue":"9","key":"2026082512221229200_qxag195-B25","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1377\/hlthaff.2025.00341","article-title":"Restrictive state opioid treatment program regulations constrain local access to methadone maintenance treatment","volume":"44","author":"Donahoe","year":"2025","journal-title":"Health Aff (Millwood)"},{"key":"2026082512221229200_qxag195-B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104141","article-title":"Typology of laws restricting access to methadone treatment in the United States: a latent class analysis","volume":"119","author":"Conway","year":"2023","journal-title":"Int J Drug Policy"},{"key":"2026082512221229200_qxag195-B27","author":"Kaiser Family Foundation"}],"container-title":["Health Affairs Scholar"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/advance-article-pdf\/doi\/10.1093\/haschl\/qxag195\/70405952\/qxag195.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/article-pdf\/4\/8\/qxag195\/70405952\/qxag195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/article-pdf\/4\/8\/qxag195\/70405952\/qxag195.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:22:17Z","timestamp":1787674937000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/article\/doi\/10.1093\/haschl\/qxag195\/8748009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1093\/haschl\/qxag195","relation":{},"ISSN":["2976-5390"],"issn-type":[{"value":"2976-5390","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,7,31]]},"article-number":"qxag195"}}